Caribou Biosciences (CRBU)
(Delayed Data from NSDQ)
$1.95 USD
-0.08 (-3.94%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.96 +0.01 (0.51%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Caribou Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CRBU 1.95 -0.08(-3.94%)
Will CRBU be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRBU based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRBU
Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates
Caribou Biosciences (CRBU) Upgraded to Buy: Here's What You Should Know
CRBU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know
Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know
Other News for CRBU
Caribou Biosciences: Key Data Updates Coming, But I'm Concerned About Near-Term Volatility
Caribou Biosciences Regains Nasdaq Compliance
Caribou Biosciences Confirms Director Elections and Auditor
Bank of America Securities Reaffirms Their Buy Rating on Caribou Biosciences (CRBU)
Caribou Biosciences (CRBU) Receives a Hold from Evercore ISI